The global pandemic has compromised many clinical trials, including SolAeroMed’s ongoing Phase II Bronchiectasis trial. Recruitment of non CF bronchiectasis patients is gaining lost momentum
SolAeroMed clinicians have published S1226 clinical trial results in CF and non CF Bronchiectasis, where positive safety and efficacy signals are described across all dosing levels and in all...
SolAeroMed CEO presented clinical study results in Bronchiectasis at the International Socieity of Aerosol Medicine meeting in Boise Idaho in May 2021. Ensuing discussion led to 3rd party interest...
